Skip to main content
Log in

Welchen Stellenwert haben Protonenpumpeninhibitoren im Rahmen der Prophylaxe von Stressulzerationen und stressassoziierten gastrointestinalen Blutungen bei Patienten auf Intensivstation?

How important are proton pump inhibitors in the prevention of stress ulcers and stress-associated gastrointestinal bleeding in ICU patients?

  • Journal Club
  • Published:
Medizinische Klinik - Intensivmedizin und Notfallmedizin Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1

Literatur

  1. Buendgens L, Koch A, Tacke F et al (2016) Prevention of stress-related ulcer bleeding at the intensive care unit: risks and benefits of stress ulcer prophylaxis. World J Crit Care Med 5:57–64

    Article  Google Scholar 

  2. Buendgens L, Tacke F (2017) Do we still need pharmacological stress ulcer prophylaxis at the ICU? J Thorac Dis 9:4201–4204

    Article  Google Scholar 

  3. Stadlbauer V (2018) Protonenpumpenhemmer für den Intensivpatienten. Sorgfältige Patientenselektion und Strategien zum Nebenwirkungsmanagement. Wien Klin Mag 21:48–53

    Article  Google Scholar 

  4. Fischbach W, Malfertheiner P, Lynen Jansen P et al (2016) S2k-Leitlinie Helicobacter pylori und gastroduodenale Ulkuskrankheit. Z Gastroenterol 54:351–352

    Google Scholar 

  5. Cook DJ, Fuller HD, Guyatt GH et al (1994) Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group. N Engl J Med 330(6):377–381

    Article  CAS  Google Scholar 

  6. Krag M, Perner A, Wetterslev J et al (2014) Stress ulcer prophylaxis versus placebo or no prophylaxis in critically ill patients. A systematic review of randomized clinical trials with meta-analysis and trial sequential analysis. Intensive Care Med 40:11–22

    Article  CAS  Google Scholar 

  7. Alhazzani W, Alshamsi F, Belley-Cote E et al (2018) Efficacy and safety of stress ulcer prophylaxis in critically ill patients: a network meta-analysis of randomized trials. Intensive Care Med 44(1):1–11

    Article  CAS  Google Scholar 

  8. Alhazzani W, Guyatt G, Alshahrani M et al (2017) Withholding Pantoprazole for stress ulcer prophylaxis in critically ill patients: a pilot randomized clinical trial and meta-analysis. Crit Care Med 7:1121–1129

    Article  Google Scholar 

  9. Alshamsi F, Belley-Cote E, Cook D et al (2016) Efficacy and safety of proton pump inhibitors for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis of randomized trials. Crit Care 20(1):120

    Article  Google Scholar 

  10. Reynolds PM, MacLaren R (2018) Re-evaluating the utility of stress ulcer prophylaxis in the critically ill patient: a clinical scenario-based meta-analysis. Pharmacotherapy. https://doi.org/10.1002/phar.2172

    Article  PubMed  Google Scholar 

  11. Alhazzani W, Alenezi F, Jaeschke RZ et al (2013) Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis. Crit Care Med 41(3):693–705

    Article  CAS  Google Scholar 

  12. Liu B, Liu S, Yin A et al (2015) Risks and benefits of stress ulcer prophylaxis in adult neurocritical care patients: a systematicreview and meta-analysis of randomized controlled trials. Crit Care 19:40

    Article  Google Scholar 

  13. Vaezi MF, Yang YX, Howden CW (2017) Complication of proton pump inhibitor therapy. Baillieres Clin Gastroenterol 153:35–48

    CAS  Google Scholar 

  14. Freedberg DE, Kim LSY (2017) The risks and benefitsis of long-term use of proton pump inhibitors: expert review and best practise advice from the American Gastroenterological Association. Baillieres Clin Gastroenterol 152:706–715

    CAS  Google Scholar 

  15. Rhodes A, Evans LE, Alhazzani W et al (2017) Surviving Sepsis Campaign. Crit Care Med 45(3):486–552

    Article  Google Scholar 

  16. Rhodes A, Evans LE, Alhazzani W et al (2017) Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med 43(3):340–341

    Article  Google Scholar 

  17. Werdan K, Ruß M, Buerke M (2011) Deutsch-österreichische S3-Leitlinie „Infarktbedingter kardiogener Schock – Diagnose, Monitoring und Therapie“. Kardiologe 5:213

    Google Scholar 

  18. Adamzik A, Bauer A, Bein TH (2017) S3-Leitlinie-Invasive Beatmung und Einsatz extrakorporaler Verfahren bei akuter respiratorischer Insuffizienz. AWMF-Leitlinienregister Nr. 001 /021, S 1–295

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to G. Michels.

Ethics declarations

Interessenkonflikt

P. Kasper, U. Janssens und G. Michels geben an, dass kein Interessenkonflikt besteht.

Additional information

Redaktion

S. Kluge, Hamburg

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kasper, P., Janssens, U. & Michels, G. Welchen Stellenwert haben Protonenpumpeninhibitoren im Rahmen der Prophylaxe von Stressulzerationen und stressassoziierten gastrointestinalen Blutungen bei Patienten auf Intensivstation?. Med Klin Intensivmed Notfmed 114, 350–354 (2019). https://doi.org/10.1007/s00063-018-0515-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00063-018-0515-x

Navigation